Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era
  2. Caplan, Margaret R.; Wilson, Eleanor M. P.; Schechter, Melissa; Cai, Catherine W.; Venner, Allison; Bishop, Rachel; Adelsberger, Joseph; Higgins, Jeanette; Roby, Gregg; Wang, Jing; Sheikh, Virginia; Sereti, Irini
  3. Journal of Virus Eradication. 2021, Sep 9; 7(3):
  1. 2.   Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia
  2. Gouel-Cheron, Aurelie; Nason, Martha; Rupert,Adam; Sheikh, Virginia; Robby, Greg; Fahle, Gary A; Sereti, Irini
  3. Open forum infectious diseases. 2020, Jan; 7(1): pii: ofaa017.
  1. 3.   Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
  2. Nath, Pulak Ranjan; Pal-Nath, Dipasmita; Mandal, Ajeet; Cam,Maggie; Schwartz, Anthony L.; Roberts, David D.
  3. CANCER IMMUNOLOGY RESEARCH. 2019, SEP; 7: 1547-1561.
  1. 4.   Host Genetics of Cytomegalovirus Pathogenesis
  2. Sezgin, Efe; An,Ping; Winkler,Cheryl
  3. Frontiers in genetics. 2019, JUL 23; 10: 616.
  1. 5.   A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge
  2. Hansen, Scott G; Marshall, Emily E; Malouli, Daniel; Ventura, Abigail B; Hughes, Colette M; Ainslie, Emily; Ford, Julia C; Morrow, David; Gilbride, Roxanne M; Bae, Jin Y; Legasse, Alfred W; Oswald,Kelli; Shoemaker,Rebecca; Berkemeier,Brian; Bosche,Bj; Hull,Mike; Womack, Jennie; Shao, Jason; Edlefsen, Paul T; Reed, Jason S; Burwitz, Ben J; Sacha, Jonah B; Axthelm, Michael K; Früh, Klaus; Lifson,Jeffrey; Picker, Louis J
  3. Science translational medicine. 2019, Jul 17; 11(501): pii: eaaw2607.
  1. 6.   Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution
  2. Melendez-Munoz, Ricardo; Marchalik, Rachel; Jerussi, Theresa; Dimitrova, Dimana; Nussenblatt, Veronique; Beri, Andrea; Rai, Khalid; Wilder,Jennifer; Barrett, A. John; Battiwalla, Minoo; Childs, Richard W.; Fitzhugh, Courtney D.; Fowler, Daniel H.; Fry, Terry J.; Gress, Ronald E.; Hsieh, Matthew M.; Ito, Sawa; Kang, Elizabeth M.; Pavletic, Steven Z.; Shah, Nirali N.; Tisdale, John F.; Gea-Banacloche, Juan; Kanakry, Christopher G.; Kanakry, Jennifer A.
  3. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019, Mar; 25(3): 577-586.
  1. 7.   Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model
  2. Valencia, Sarah; Gill, Rachel B.; Dowdell, Kennichi C.; Wang,Yanmei; Hornung, Ron; Bowman, J. Jason; Lacayo, Juan C.; Cohen, Jeffrey I.
  3. Vaccine. 2019, Jan 7; 37(7): 333-342.
  1. 8.   Implications for Gene Therapy-Limiting Expression of IL-2R gamma(c) Delineate Differences in Signaling Thresholds Required for Lymphocyte Development and Maintenance
  2. Orr, S. J.; Roessler, S.; Quigley, L.; Chan, T.; Ford, J. W.; O'Connor, G. M.; McVicar, D. W.
  3. Journal of Immunology. 2010, Aug; 185(3): 1393-1403.
  1. 9.   Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients
  2. Hendrickson, S. L.; Jabs, D. A.; Van Natta, M.; Lewis, R. A.; Wallace, D. C.; O'Brien, S. J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2010, Apr; 53(4): 451-455.
  1. 10.   HLA Class I Subtype-Dependent Expansion of KIR3DS1(+) and KIR3DL1(+) NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection
  2. Alter, G.; Rihn, S.; Walter, K.; Nolting, A.; Martin, M.; Rosenberg, E. S.; Miller, J. S.; Carrington, M.; Altfeld, M.
  3. Journal of Virology. 2009 83(13): 6798-6805.
  1. 11.   Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
  2. Hansen, S. G.; Vieville, C.; Whizin, N.; Coyne-Johnson, L.; Siess, D. C.; Drummond, D. D.; Legasse, A. W.; Axthelm, M. K.; Oswald, K.; Trubey, C. M.; Piatak, M.; Lifson, J. D.; Nelson, J. A.; Jarvis, M. A.; Picker, L. J.
  3. Nature Medicine. 2009 15(3): 293-299.
  1. 12.   Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome
  2. Belanger, S.; Tai, L. H.; Anderson, S. K.; Makrigiannis, A. P.
  3. Genes and Immunity. 2008 9(6): 509-521.
  1. 13.   Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1
  2. Gruber, S. G.; Luciani, M. G.; Grundtner, P.; Zdanov, A.; Gasche, C.
  3. European Journal of Immunology. 2008 38(12): 3365-3375.
  1. 14.   Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC
  2. Tai, L. H.; Goulet, M. L.; Belanger, S.; Toyama-Sorimachi, N.; Fodil-Cornu, N.; Vidal, S. M.; Troke, A. D.; McVicar, D. W.; Makrigiannis, A. P.
  3. Journal of Experimental Medicine. 2008 205(13): 3187-3199.
  1. 15.   Antiviral synergism
  2. Carrington, M.
  3. Nature Genetics. 2005, JUN; 37(6): 565-566.
  1. 16.   Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins
  2. Morcock, D. R.; Thomas, J. A.; Gagliardi, T. D.; Gorelick, R. J.; Roser, J. D.; Chertova, E. N.; Bess, J. W.; Ott, D. E.; Sattentau, Q. J.; Frank, I.; Pope, M.; Lifson, J. D.; Henderson, L. E.; Crise, B. J.
  3. Journal of Virology. 2005, FEB; 79(3): 1533-1542.
  1. 17.   Independent control of Ly49g alleles: Implications for NK cell repertoire selection and tumor cell killing
  2. Makrigiannis, A. P.; Rousselle, E.; Anderson, S. K.
  3. Journal of Immunology. 2004 172(3): 1414-1425.
  1. 18.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 19.   MICA and recovery from hepatitis C virus and hepatitis B virus infections
  2. Karacki, P. S.; Gao, X.; Thio, C. L.; Thomas, D. L.; Goedert, J. J.; Vlahov, D.; Kaslow, R.; Strathdee, S.; Hilgartner, M. W.; O'Brien, S. J.; Carrington, M.
  3. Genes and Immunity. 2004 5(4): 261-266.
  1. 20.   Aberrant DAP12 signaling in the 129 strain of mice: Implications for the analysis of gene-targeted mice
  2. McVicar, D. W.; Winkler-Pickett, R.; Taylor, L. S.; Makrigiannis, A.; Bennett, M.; Anderson, S. K.; Ortaldo, J. R.
  3. Journal of Immunology. 2002 169(4): 1721-1728.
  1. 21.   Susceptibility to psoriatic arthritis: Influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles
  2. Martin, M. P.; Nelson, G.; Lee, J. H.; Pellett, F.; Gao, X. J.; Wade, J.; Wilson, M. J.; Trowsdale, J.; Gladman, D.; Carrington, M.
  3. Journal of Immunology. 2002 169(6): 2818-2822.
  1. 22.   A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens
  2. Strickler, H. D.; Goedert, J. J.; Butel, J. S.; Daniel, R.; Freymuth, F.; Gibbs, A.; Griffiths, D. J.; Jablons, D.; Jasani, B.; Jones, C.; Lednicky, J. A.; Miller, C. W.; Radu, C.; Richards, W. G.; Shah, K. V.; You, L.; Corson, J. M.; Gerwin, B.; Harris, C.; Sugarbaker, D. J.; Egan, W.; Lewis, A. M.; Krause, P. R.; Peden, K.; Levine, A. S.; Melnick, S.; Cosentino, M.; da Costa, M.; Devairrakam, V.; Ji, J.; Palefsky, J.; Rasmussen, L.; Shea, K.; Wacholder, S.; Waters, D.; Wright, T.
  3. Cancer Epidemiology Biomarkers & Prevention. 2001 10(5): 523-532.
  1. 23.   Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen- specific roles in resistance to infection
  2. Collazo, C. M.; Yap, G. S.; Sempowski, G. D.; Lusby, K. C.; Tessarollo, L.; Woude, G. F. V.; Sher, A.; Taylor, G. A.
  3. Journal of Experimental Medicine. 2001 194(2): 181-187.
  1. 24.   Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP
  2. Taylor, G. A.; Collazo, C. M.; Yap, G. S.; Nguyen, K.; Gregorio, T. A.; Taylor, L. S.; Eagleson, B.; Secrest, L.; Southon, E. A.; Reid, S. W.; Tessarollo, L.; Bray, M.; McVicar, D. W.; Komschlies, K. L.; Young, H. A.; Biron, C. A.; Sher, A.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2000 97(2): 751-755.
  1. 25.   Use of mutant SIV DNA immunization to mimic attenuated virus vaccines
  2. Arthur, L. O.; Gorelick, R. J.; Benveniste, R. E.; Lifson, J. D.; Yovandich, J. L.; Rossio, J. L.; Esser, M. T.; Bess, J. W.; Henderson, L. E.
  3. Conference on Retroviruses and Opportunistic Infections. 1999, 74 (abstract no. 40)-74 (abstract no. 40).
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel